New Delhi: GlaxoSmithKline (GSK)Pharmaceuticals on Monday reported 22.67% fall in standalone net profit to 100.77 crore for the quarter ended 30 September 2018.

The company had posted a net profit of 130.32 crore in the year-ago period, GSK Pharma said in a BSE filing.

Total income of the company stood at 831.13 crore for the reported quarter. It was 845.89 crore in the second quarter of 2017-18.

Shares of GSK Pharma were trading at 1,379.30 per scrip on BSE, down 3.11% from the previous close.